Abstract:Introduction: Melittin is a potent antimicrobial peptide from bee venom that is effective against both Gram-positive and Gram-negative bacteria. However, it is extremely toxic to mammalian cells and, as yet, has no clinical use. Modifications to its amino acid sequence, cyclization, truncation, and dimerization have been attempted in order to reduce its toxicity whilst maintaining its antimicrobial activity. Methods: In this study, we targeted the three lysine residues present in melittin and substituted them with lysine homologs containing shorter side chains (ornithine, Orn, diaminobutyric acid, Dab, and diaminopropanoic acid, Dap) and made both parallel and antiparallel melittin dimers to observe how lysine substitution and dimerization affects its activity and toxicity. The antibacterial activity of melittin and its analogs was tested against S. aureus (Gram-positive bacteria) and E. coli (Gram-negative bacteria), and cytotoxicity was tested against the mammalian cell lines HEK293 and H4IIE. Results: Overall, dimerization and lysine substitution exhibited improved antimicrobial activity toward E. coli and limited improvement toward S. aureus. However, mammalian cell toxicity was only marginally reduced compared to native melittin. Interestingly, the parallel dimer was found to be marginally more active than the antiparallel dimer, indicating orientation maybe important for activity, although both dimers were less effective than the native and Lys-analog peptides toward S. aureus . Of the Lys substitutions, Dab and Dap improved melittin's activity toward E. coli . Discussion: Dimerization and Lys substitution of melittin improved the antimicrobial activity toward Gram-negative bacteria but did not significantly improve its activity toward Gram-positive bacteria. Some analogs also displayed reduced toxicity toward HEK293 and H4IIE cells but overall remained toxic at bactericidal concentrations. Our data indicates that although highly antibacterial, melittin's toxicity is the major drawback in its potential use.

New N-Terminal Fatty-Acid-Modified Melittin Analogs with Potent Biological Activity

Enhancing Selective Antimicrobial and Antibiofilm Activities of Melittin through 6-Aminohexanoic Acid Substitution

Discovery of Melittin as Triple-Action Agent: Broad-Spectrum Antibacterial, Anti-Biofilm, and Potential Anti-Quorum Sensing Activities

Studies on synthesis and biological activities of analogues of melittin

Dimerization and lysine substitution of melittin have differing effects on bacteria

Design, synthesis, and antiproliferative activities of stapled melittin peptides

Design and Synthesis of New N-terminal Fatty Acid Modified-Antimicrobial Peptide Analogues with Potent in Vitro Biological Activity.

Action mechanism of melittin-derived antimicrobial peptides, MDP1 and MDP2, de novo designed against multidrug resistant bacteria

The Novel Peptide Adjuvants Potentiate Antimicrobial Properties of Melittin Against Methicillin-Resistant Staphylococcus Aureus and Their Efficacy As a Potential Food Preservative

Antimicrobial and Hemolytic Activities of Melittin and Its Analogues and Their Interactions with Phospholipid Membranes

The current landscape of the antimicrobial peptide melittin and its therapeutic potential

Acid-Activated Melittin for Targeted and Safe Antitumor Therapy.

Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions.

Enhancement of cell membrane poration by the antimicrobial peptide Melp5

Design of pH-responsive antimicrobial peptide melittin analog-camptothecin conjugates for tumor therapy

A molecular architectural design that promises potent antimicrobial activity against multidrug-resistant pathogens

Antimicrobial Properties And Membrane-Active Mechanism Of A Potential Alpha-Helical Antimicrobial Derived From Cathelicidin Pmap-36

Deletion of two C-terminal Gln residues of 12–26-residue fragment of melittin improves its antimicrobial activity

Semisynthetic Macrocyclic Lipo-lanthipeptides Display Antimicrobial Activity Against Bacterial Pathogens

Design, characterization and expression of a novel hybrid peptides melittin (1–13)-LL37 (17–30)

Biochemical Property and Membrane-Peptide Interactions of De Novo Antimicrobial Peptides Designed by Helix-Forming Units.